Charles River Laboratories International Inc (CRL)

Industry Diagnostics & Research

This stock can be held in an Investment Account

Sell

$165.00

Buy

$200.00

arrow-down$-1.40 (-0.72%)

Prices updated at 13 Dec 2025, 00:16 EST

Prices minimum 15 mins delay

Prices in USD

Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries.

S&P 500

-1.07%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	4,129m	4,050m
	1,503m	1,332m
	617m	442m
	14.95	10.92
	475m	10m
	1,032m	581m
Sales, General and administrative	748m	751m
Interest expenses	137m	126m
Provision for income taxes	101m	68m
Operating expenses	885m	889m
Income before taxes	581m	93m
Net income available to common shareholders	475m	10m
	9.27	0.2
Net interest income	-132m	-118m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	9.22	0.2
Free cash flow per share	7.161	10.8587
Book value/share	64.3966	73.9577
Debt equity ratio	0.852511	0.78694

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	1,609m	1,403m
Current liabilities	1,055m	994m
Total capital	6,244m	5,702m
Total debt	3,066m	2,724m
Total equity	3,597m	3,462m
Total non current liabilities	-	-
Loans	2,647m	2,240m
Total assets	8,195m	7,528m
Total liabilities	-	-
Cash and cash equivalents	277m	195m
Common stock	51m	51m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	241m	284m
Cash dividends paid	-	-
	365m	502m
Investments (gains) losses	-563m	-245m
	284m	206m
Net income	-	-
	684m	735m
	-319m	-233m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.